Litigation Details for Gilead Sciences, Inc. v. Lupin Limited (D. Del. 2021)
✉ Email this page to a colleague
Gilead Sciences, Inc. v. Lupin Limited (D. Del. 2021)
Docket | ⤷ Sign Up | Date Filed | 2021-11-15 |
Court | District Court, D. Delaware | Date Terminated | 2023-03-15 |
Cause | 35:271 Patent Infringement | Assigned To | Maryellen Noreika |
Jury Demand | None | Referred To | |
Patents | 8,754,065; 9,296,769 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Gilead Sciences, Inc. v. Lupin Limited
Details for Gilead Sciences, Inc. v. Lupin Limited (D. Del. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2021-11-15 | 3 | ANDA Form | 10/06/2021. Date of Expiration of Patent: U.S. Patent Nos. 8,754,065 and 9,296,769 expire on August 15… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …2021 15 March 2023 1:21-cv-01615 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2023-03-15 | 35 | Judgment - Consent | Limited (“Lupin”) for infringement of U.S. Patent Nos. 8,754,065, and 9,296,769. Gilead and Lupin…JUDGMENT AND DISMISSAL ORDER This action for patent infringement having been brought by Plaintiff Gilead…2021 15 March 2023 1:21-cv-01615 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |